Abstract
Development of point-of-care (POC) for saliva-based, noninvasive detection of OSCC is an active area of research. Portable and easy-to-use biomedical devices and advanced electrochemical platforms (OFNASET) or simple paper-strip chromatography (e.g., OncAlert ®), based on a single or a panel of salivary biomarkers, are already available for clinical use. In this chapter, the emerging core technologies and approaches assisting early POC detection are discussed. Knowledge from closely related fields like nanotechnology is also summarized to provide insight on possible future approaches that can be tailored for oral cancer detection. POC for oral cancer can be designed to work on a potential biomarker candidate (validated in multi-cohort and multiethnic studies) among the wide range of 100 signature analytes from proteins to RNA, cytomorphometry of exfoliated cells in saliva (analogous to circulating tumor cells in plasma), or through high-throughput screening of salivary exosomes for potential signatures. Surface-enhanced Raman scattering (SERS) was also used as a saliva assay previously, and such attempts will evolve significantly if saliva samples are mucin-free. ELISA is a common method for low-cost protein detection, with great POC potential. Its performance can be optimized through bead and nanoparticle technology. Sophisticated Luminex multi-analyte profiling (xMAP) technology and metal-linked immunosorbent assay (MeLISA), based on ELISA and biocatalytic ability of enzymes, were already reported with high sensitivity and specificity, which can be extrapolated to saliva samples. Some technologies have also assisted detection of mutations, such as “electric field-induced release and measurement” (EFIRM) recently deployed for identification of EGFR mutations through saliva samples. In this chapter, we have narrated the current trend and future opportunities for POC development in saliva-based oral cancer detection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wong DT. Towards a simple, saliva-based test for the detection of oral cancer 'oral fluid (saliva), which is the mirror of the body, is a perfect medium to be explored for health and disease surveillance'. Expert Rev Mol Diagn. 2006;6:267–72.
Kaczor-Urbanowicz KE, Carreras-Presas CM, Kaczor T, Michael T, Wei F, Garcia-Godoy F, Wong DTW. Emerging technologies for salivaomics in cancer detection. J Cell Mol Med. 2017;21:640–7.
Daniel Malamud, Isaac R. Rodriguez-Chavez. Saliva as a Diagnostic fluid. Dent Clin N Am 2011; 55: 159–178.
Lee Y-H, Saliva DTW. An emerging biofluid for early detection of diseases. Am J Dent. 2009;22:241–8.
Ziober BL, Mauk MG, Falls EM, Chen Z, Ziober AF, Bau HH. Lab-on-a-chip for oral cancer screening and diagnosis. Head Neck. 2008;30:111–21.
Malhotra R, Patel V, Chikkaveeraiah BV, Munge BS, Cheong SC, Zain RB, et al. Ultrasensitive detection of Cancer biomarkers in the clinic using a nanostructured microfluidic Array. Anal Chem. 2012;84:6249–55.
Munge BS, Coffey AL, Doucette JM, Somba BK, Malhotra R, Patel V, et al. Nanostructured immunosensor for attomolar detection of cancer biomarker interleukin-8 using massively labeled superparamagnetic particles. Angew Chem Int Ed Engl. 2011;50:7915–8.
Kumar S, Kumar S, Ali MA, Anand P, Agrawal VV, John R, Maji S, Malhotra BD. Microfluidic-integrated biosensors: prospects for point-of-care diagnostics. Biotechnol J. 2013;8:1267–79.
Zhang JZ, Nagrath S. Microfluidics and Cancer: are we there yet? Biomed Microdevices. 2013;15:595–609.
Ying L, Wang Q. Microfluidic chip-based technologies: emerging platforms for cancer diagnosis. BMC Biotechnol. 2013;13:76.
Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip. 2010;10:505–11.
Wang H, Liu W, Zhang X, Xu X, Kang Z, Li S, et al. Toward point-of-care testing for JAK2 V617F mutation on a microchip. J Chromatogr A. 2015;1410:28–34.
Hayama FH, Motta AC, Silva Ade P, Migliari DA. Liquid-based preparations versus conventional cytology: specimen adequacy and diagnostic agreement in oral lesions. Med Oral Patol Oral Cir Bucal. 2005;10:115–22.
Navone R, Burlo P, Pich A, Pentenero M, Broccoletti R, Marsico A, et al. The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma. Cytopathology. 2007;18:356–60.
Navone R. Cytology of the oral cavity: a re-evaluation. Pathologica. 2009;101:6–8.
McDevitt J, Weigum SE, Floriano PN, Christodoulides N, et al. A new bio-nanochip sensor aids oral cancer detection. SPIE Newsroom. 2011;003547
Weigum SE, Floriano PN, Redding SW, Yeh CK, Westbrook SD, McGuff HS, et al. Nano-bio-chip sensor platform for examination of oral exfoliative cytology. Cancer Prev Res (Phila). 2010;3:518–28.
Weigum SE, Floriano PN, Christodoulides N, McDevitt JT. Cell-based sensor for analysis of EGFR biomarker expression in oral cancer. Lab Chip. 2007;7:995–1003.
Abram TJ, Floriano PN, Christodoulides N, James R, Kerr AR, Thornhill MH, et al. ‘Cytology-on-a-chip’ based sensors for monitoring of potentially malignant oral lesions. Oral Oncol. 2016; 60: 103-11.
Whitesides GM, Wilding P. Lab on a stamp: paper-based diagnostic tools. Interview by Molly Webster and Vikram Sheel Kumar Clin Chem 2012; 58:956–8.
Yetisen AK, Akram MS, Lowe CR. Paper-based microfluidic point-of-care diagnostic devices. Lab Chip. 2013;13:2210–51.
Alicia D. Powers, Sean P. Palecek, Ph. D. Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients. J Healthc Eng. 2012;3:503–34.
Murdock RC, Shen L, Griffin DK, Kelley-Loughnane N, Papautsky I, Hagen JA. Optimization of a paper-based ELISA for a human performance biomarker. Anal Chem. 2013;85:11634–42.
Tan W, Sabet L, Li Y, Yu T, Klokkevold PR, Wong DT, et al. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron. 2008;24:266–71.
Sanjay ST, Dou M, Sun J, Li X. A paper/polymer hybrid microfluidic microplate for rapid quantitative detection of multiple disease biomarkers. Sci Rep. 2016;6:30474.
Markopoulos AK, Michailidou EZ, Tzimagiorgis G. Salivary markers for oral Cancer detection. Open Dent J. 2010;4:172–8.
Venugopal A, Uma Maheswari TN. Expression of matrix metalloproteinase-9 in oral potentially malignant disorders: a systematic review. J Oral Maxillofac Pathol. 2016;20:474–9.
Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis. 2008;14:705–12.
Dincer C, Bruch R, Kling A, Dittrich PS, Urban GA. Multiplexed Point-of-Care Testing - xPOCT. Trends Biotechnol. 2017;35:728–42.
Baker HN, Murphy R, Lopez E, Garcia C. Conversion of a Capture ELISA to a Luminex xMAP Assay using a Multiplex Antibody Screening Method. J Vis Exp. 2012; (65): 4084. (refervedio).
Yu R-J, Ma W, Liu X-Y, Jin H-Y, Han H-X, Wang H-Y, Long Y-T, et al. Metal-linked Immunosorbent Assay (MeLISA): the enzyme-free alternative to ELISA for biomarker detection in serum. Theranostics. 2016;6:1732–9.
Malhotra R, Patel V, Vaqué JP, Silvio Gutkind J, Rusling JF. Ultrasensitive electrochemical Immunosensor for oral Cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification. Anal Chem. 2010;82:3118–23.
Hart RW, Mauk MG, Liu C, Qiu X, Thompson JA, Chen D, Malamud D, Abrams WR, Bau HH. Point-of-careoral-baseddiagnostics. Oral Dis. 2011;17:745–52.
Herr AE, Hatch AV, Throckmorton DJ, Tran HM, Brennan JS, Giannobile WV, Singh AK. Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A. 2007;104:5268–73.
Oliveira-Rodríguez M, López-Cobo S, Reyburn HT, Costa-García A, López-Martín S, Yáñez-Mó M, et al. Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids. J Extracell Vesicles. 2016;5:31803.
Segal A, Wong DT. Salivary diagnostics: enhancing disease detection and making medicine better. Eur J Dent Educ. 2008;12:22–9.
Wei F, Patel P, Liao W, Chaudhry K, Zhang L, Arellano-Garcia M, et al. Electrochemical sensor for multiplex biomarkers detection. Clin Cancer Res. 2009;15:4446–52.
Fang WE, Wong DT. Point-of-care platforms for salivary diagnostics. Chin J Dent Res. 2012;15:7–15.
Wei F, Lin CC, Joon A, Feng Z, Troche G, Lira ME, et al. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med. 2014;190:1117–26.
Pu D, Liang H, Wei F, Akin D, Feng Z, Yan Q, et al. Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study. Thorac Cancer. 2016; 7: 428-36.
Aro K, Wei F, Wong DT, Michael T. Saliva liquid biopsy for point-of-care applications. Front Public Health. 2017;5:77.
Yang J, Wei F, Schafer C, Wong DT. Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva. PLoS One. 2014;9:e110641.
Tu M, Wei F, Yang J, Wong D. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM). J Vis Exp. 2015;95:52439.
Tan Y, Wei X, Zhao M, Qiu B, Guo L, Lin Z, Yang HH. Ultraselective homogeneous electrochemical biosensor for DNA species related to oral cancer based on nicking endonuclease assisted target recycling amplification. Anal Chem. 2015;87:9204–8.
Kim J, Imani S, de Araujo WR, Warchall J, Valdés-Ramírez G, Paixão TRLC, Mercier PP, Wang J. Wearable salivary uric acid mouthguard biosensor with integrated wireless electronics. Biosens Bioelectron. 2015;74:1061–8.
Kim J, Valdés-Ramírez G, Bandodkar AJ, Jia W, Martinez AG, Ramírez J et al. Non-invasive mouthguard biosensor for continuous salivary monitoring of metabolites. Analyst. 2014;139:1632–6.
Liang YH, Chang CC, Chen CC, Chu-Su Y, Lin CW. Development of an au/ZnO thin film surface plasmon resonance-based biosensor immunoassay for the detection of carbohydrate antigen 15-3 in human saliva. Clin Biochem. 2012;45:1689–93.
Munge BS, Krause CE, Malhotra R, Patel V, Silvio Gutkind J, Rusling JF. Electrochemical Immunosensors for Interleukin-6.Comparison of carbon nanotube Forest and gold nanoparticle platforms. Electrochem Commun. 2009;11:1009–12.
Zhang Y, Chen R, Xu L, Ning Y, Xie S, Zhang GJ. Silicon nanowire biosensor for highly sensitive and multiplexed detection of oral squamous cell carcinoma biomarkers in saliva. Anal Sci. 2015;31:73–8.
Kwon SM, Kang GB, Kim YT, Kim YH, Ju BK. In-situ detection of C-reactive protein using silicon nanowire field effect transistor. JNanosci Nanotechnol. 2011;11:1511–4.
Wang HB, Wu S, Chu X, Yu RQ. A sensitive fluorescence strategy for telomerase detection in cancer cells based on T7 exonuclease-assisted target recycling amplification. Chem Commun (Camb). 2012;48:5916–8.
Liu X, Li W, Hou T, Dong S, Yu G, Li F. Homogeneous electrochemical strategy for human telomerase activity assay at single-cell level based on T7 exonuclease-aided target recycling amplification. Anal Chem. 2015;87:4030–6.
Hayakawa M, Kodama M, Sato S, Tomoeda-Mori K, Haraguchi K, Habu M, et al. Electrochemical telomeraseassay for screening for oral cancer. Br J Oral Maxillofac Surg. 2016; 54:301-5.
Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl. 2008;1:17–32.
Tiwari PM, Vig K, Dennis VA, Singh SR. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials (Basel). 2011;1:31–63.
Huang X, O'Connor R, Kwizera EA. Gold nanoparticle based platforms for circulating Cancer marker detection. Nano. 2017;1:80–102.
Kah JC, Kho KW, Lee CG, James C, Sheppard R, Shen ZX et al. Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomedicine 2007; 2: 785–798.
Wang X, Qian X, Beitler JJ, Chen ZG, Khuri FR, Lewis MM et al. Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles. Cancer Res. 2011; 71: 1526–1532.
Chikkaveeraiah BV, Mani V, Patel V, Gutkind JS, Rusling JF. Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum. Biosens Bioelectron. 2011;26:4477–83.
Singh SP, Deshmukh A, Chaturvedi P, Murali KC. In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt. 2012;17:105002.
Xue L, Li Y, Cai Q, Sun P, Luo X, Yan B. Ramanspectral characteristics of oralsquamous cell carcinoma, epithelial dysplasia and normal mucosa. Zhonghua Kou Qiang Yi Xue Za Zhi. 2015;50:18–22.
Li XZ, Bai J, Lin J, et al. Serum fluorescence and Raman spectra for diagnosis of cancer. Proc SPIE. 2001;4432:124–30.
Sahu A, Sawant S, Mamgain H, Krishna CM. Raman spectroscopy of serum: an exploratory study for detection of oral cancers. Analyst. 2013;138:4161–74.
Singh SP, Sahu A, Deshmukh A, Chaturvedi P, Krishna CM. In vivo Raman spectroscopy of oral buccal mucosa: a study on malignancy associated changes (MAC)/cancer field effects (CFE). Analyst. 2013;138:4175–82.
Tan Y, Yan B, Xue L, Li Y, Luo X, Ji P. Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oralsquamous cell carcinoma. Lipids Health Dis. 2017;16:73.
Yan B, Li B, Wen Z, Luo X, Xue L, Li L. Label-free blood serum detection by using surface-enhanced Raman spectroscopy and support vector machine for the preoperative diagnosis of parotid gland tumors. BMC Cancer. 2015;15:650.
Tu Q, Chang C. Diagnostic applications of Raman spectroscopy. Nanomedicine. 2012;8:545–58.
Vendrell M, Maiti KK, Dhaliwal K, Chang YT. Surface-enhanced Raman scattering in cancer detection and imaging. Trends Biotechnol. 2013;31:249–57.
Nolan JP, Duggan E, Liu E, Condello D, Dave I, Stoner SA. Single cell analysis using surface enhanced Raman scattering (SERS) tags. Methods. 2012;57:272–9.
Qian X, Peng XH, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol. 2008;26:83–90.
Owens P, Phillipson N, Perumal J, O'Connor GM, Olivo M. Sensing of p53 and EGFR biomarkers using high efficiency SERS substrates. Biosensors (Basel). 2015;5:664–77.
Lin D, Pan J, Huang H, Chen G, Qiu S, Shi H, et al. Label-free blood plasma test based on surface-enhanced Raman scattering for tumor stages detection in nasopharyngeal cancer. Sci Rep. 2014; 4:4751.
Feng S, Chen R, Lin J, Pan J, Chen G, Li Y, et al. Nasopharyngeal cancer detection based on blood plasma surface-enhanced Raman spectroscopy and multivariate analysis. Biosens Bioelectron. 2010;25:2414–9.
Gong T, Kong KV, Goh D, Olivo M, Yong K-T. Sensitive surface enhanced Raman scattering multiplexed detection of matrix metalloproteinase 2 and 7 cancer markers. Biomed Opt Express. 2015;6:2076–87.
Head SR, Kiyomi Komori H, LaMere SA, Whisenant T, Van Nieuwerburgh F, Salomon DR. Library construction for next-generation sequencing: Overviews and challenges. Biotechniques. 2014;56:61.
Li Y, Wen ZN, Li LJ, Li ML, Gao N, Guo YZ. Research on the Raman spectral character and diagnostic value of squamous cell carcinoma of oral mucosa. J Raman Spectrosc. 2010;41:142–7.
Stahelin RV. Surface plasmon resonance: a useful technique for cell biologists to characterize biomolecular interactions. Mol Biol Cell. 2013;24:883–6.
El-Sayed IH. Nanotechnology in head and neckcancer: the race is on. Curr Oncol Rep. 2010;12:121–8.
Poser E, Genovese I, Masciarelli S, Bellissimo T, Fazi F, Colotti G. Surface Plasmon resonance: a useful strategy for the identification of small molecule Argonaute 2 protein binders. Methods Mol Biol. 2017;1517:223–37.
Piliarik M, Vaisocherová H, Homola J. Surface plasmon resonance biosensing. Methods Mol Biol. 2009;503:65–88.
Drescher DG, Ramakrishnan NA, Drescher MJ. Surface Plasmon resonance (SPR) analysis of binding interactions of proteins in inner-ear sensory epithelia. Methods Mol Biol. 2009;493:323–43.
Dudak FC, Boyaci IH. Rapid and label-free bacteria detection by surface plasmon resonance (SPR) biosensors. Biotechnol J. 2009;4:1003–11.
Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014;32:490.
Yakob M, Fuentes L, Wang MB, Abemayor E, Wong DTW. Salivary biomarkers for detection of oral squamous cell carcinoma – current state and recent advances. Curr Oral Health Rep. 2014;1:133–41.
El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005;5:829–34.
Maiolo D, Paolini L, Di Noto G, Zendrini A, Berti D, Bergese P, et al. Colorimetric nanoplasmonic assay to determine purity and titrate extracellular vesicles. Anal Chem. 2015;87:4168–76.
Xie X, Xu W, Liu X. Improving colorimetric assays through protein enzyme-assisted gold nanoparticle amplification. Acc Chem Res. 2012;45:1511–20.
Cordeiro M, Ferreira Carlos F, Pedrosa P, Lopez A, Baptista PV. Gold Nanoparticles for Diagnostics: Advances towards Points of Care. Diagnostics (Basel).2016;6(4).pii: E43.
Chen P, Selegård R, Aili D, Liedberg B. Peptide functionalized gold nanoparticles for colorimetric detection of matrilysin (MMP-7) activity. Nanoscale. 2013;5:8973–6.
Zhang Y, McKelvie ID, Cattrall RW, Kolev SD. Colorimetric detection based on localised surface plasmon resonance of gold nanoparticles: merits, inherent shortcomings and future prospects. Talanta. 2016;152:410–22.
Latorre A, Posch C, Garcimartín Y, Ortiz-Urda S, Somoza Á. Single-point mutation detection in RNA extracts using gold nanoparticles modified with hydrophobic molecular beacon-like structures. Chem Commun (Camb). 2014;50:3018–20.
Sun L, Zhang Z, Wang S, Zhang J, Li H, Ren L, et al. Effect of pH on the interaction of gold nanoparticles with DNA and application in the detection of human p53 gene mutation. Nanoscale Res Lett. 2008;4:216–20.
Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science. 2003;301:1884–6.
Laromaine A, Koh L, Murugesan M, Ulijn RV, Stevens MM. Protease-triggered dispersion of nanoparticle assemblies. J Am Chem Soc. 2007;129:4156–7.
Maher RC, Maier SA, Cohen LF, Koh L, Laromaine A, Dick JAG, Stevens MM. Exploiting SERS hot spots for disease-specific enzyme detection. J Phys Chem C. 2010;114:7231–5.
Andrew St. John, Christopher P Price. Existing and emerging technologies for point-of-care testing. Clin Biochem Rev. 2014;35:155–67.
St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:929–35.
de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One. 2010;5:e11148.
Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res. 2004;10:8442–50.
Elashoff D, Zhou H, Reiss J, Wang J, Henson B, Shen H, et al. Pre-validation of salivary biomarkers for oral Cancer detection. Cancer Epidemiol Biomark Prev. 2012;21:664–72.
Yamazaki K, Nakajima T, Gemmell E, Polak B, Seymour GJ, Hara K. IL-4- and IL-6-producing cells in human periodontal disease tissue. J Oral Pathol Med. 1994;23:347–53.
Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000;287:2017–9.
Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DT. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev. 2013;26:781–91.
Stuani VT, Rubira CM, Sant'Ana AC, Santos PS. Salivary biomarkers as tools for oral squamous cell carcinoma diagnosis: a systematic review. Head Neck. 2017;39:797–811.
Acknowledgment
Support from Ronnie James Dio Stand Up and Shout Cancer Research Fund.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Panta, P., Wong, D.T.W. (2019). Saliva-Based Point-of-Care in Oral Cancer Detection: Current Trend and Future Opportunities. In: Panta, P. (eds) Oral Cancer Detection. Springer, Cham. https://doi.org/10.1007/978-3-319-61255-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-61255-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61254-6
Online ISBN: 978-3-319-61255-3
eBook Packages: MedicineMedicine (R0)